EWTX
Edgewise Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -7.1% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | +1 | 735.20K | $29.85M | +1 | n/a |
| Q2 2026 | 88 | +9 | 40.35M | $1.62B | +14 | −4 |
| Q1 2026 | 81 | +4 | 39.90M | $1.24B | +9 | −6 |
| Q4 2025 | 77 | +2 | 40.83M | $1.01B | +3 | n/a |
| Q3 2025 | 14 | +1 | 17.98M | $291.62M | +1 | −1 |
| Q2 2025 | 11 | -4 | 17.73M | $232.39M | n/a | −4 |
| Q1 2025 | 12 | -2 | 5.61M | $123.36M | n/a | −2 |
| Q4 2024 | 14 | 0 | 7.38M | $197.14M | +1 | −1 |
| Q3 2024 | 13 | +3 | 6.24M | $166.42M | +3 | n/a |
| Q2 2024 | 10 | n/a | 8.30M | $149.57M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 1.72M | n/a | $45.81M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 1.60M | +0.1% | $42.74M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Viking Global Investors ✦ | 1.22M | -17.3% | $32.71M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Millennium Management ✦ | 888.97K | -9.9% | $23.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 686.37K | +50.7% | $18.33M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 469.45K | -12.8% | $12.53M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 7 | Adage Capital Partners ✦ | 240.00K | +1015.8% | $6.41M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 202.89K | -1.2% | $5.42M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 9 | Two Sigma Investments ✦ | 131.67K | -49.6% | $3.52M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 106.56K | Nuevo | $2.85M | 0.0% | New | 1 | SEC ↗ |
| 11 | Norges Bank ✦ (pasivo) | 47.76K | 0.0% | $1.28M | 0.0% | Held | 2 | SEC ↗ |
| 12 | Marshall Wace ✦ | 29.89K | -94.8% | $798,142 | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 13 | T. Rowe Price ✦ | 29.05K | +22.0% | $776,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 9.37K | +4.7% | $250,073 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Point72 Asset Management | $2.85M | 0.0% |
Posición cerrada
| Renaissance Technologies | $733,041 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 213 tenedores, 118.39M acciones, $3.71B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 2.92K acc. · $126,704
Officer · 2.17K acc. · $95,075
Officer · 304 acc. · $13,529
Officer · 150 acc. · $6,666
Officer · 2.48K acc. · $108,154
Officer · 2.84K acc. · $124,303
Officer · 2.78K acc. · $121,463
Officer · 104 acc. · $4,620
Officer · 800 acc. · $35,614
Officer, Director · 8.28K acc. · $361,315
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología